Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2025 ,inter alia, to consider and approve To discuss and approve the following ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bacil Pharma Ltd has informed BSE that a Board of Directors meeting is scheduled for 05th September 2025. The agenda includes discussion on the notice and logistics for the 38th Annual General Meeting (AGM), and review of the Director's Report for FY2024-25. The Board will also discuss matters related to the conversion of loans into equity shares of the company. The intimation is signed by Director Chaitali Kalpataru Shah. The company is listed on BSE under scrip code 524516.
Routine procedural intimation. Shareholders should watch for outcomes of the 'Loan to Equity shares' discussion, as it could potentially impact shareholding dilution or capital structure. No immediate stock price action is expected from the notice itself.